Barologics develops disruptive technology to treat hypertension through closed-loop stimulation.
Barologics has raised $11.5M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Barologics's investors include Sante Ventures.
Barologics is headquartered in Carver, United States.
Barologics develops disruptive technology to treat hypertension through closed-loop stimulation.
Barologics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Barologics — Funding & Investors." VCBacked, January 7, 2022, https://www.vcbacked.co/company/barologics. Accessed August 16, 2026.
VCBacked. (2022). Barologics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/barologics
{{cite web |title=Barologics — Funding & Investors |url=https://www.vcbacked.co/company/barologics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated